Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery
NCT05290129Recruiting
- Sponsor
- Mount Sinai Hospital
- Start
- Aug 2022
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Double-blind trial of oxytocin in postpartum hemorrhage (PPH) (10 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Uterine tone up to discharge from the post anesthetic care unit (PACU) at 2 hours. Started Aug 2022; status: recruiting.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05290129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05290129.